IGF1 and Alzheimer disease: Further, impaired insulin/IGF1 signaling in the brain not only has been linked to increased risk for premature cognitive decline, dementia, and AD but also increases Aβ42 level (Long et al., 2019), causing hypometabolism of neurons (Sivanesan et al., 2018).